RHI vs TERN · P/E 21, rev $2.64B vs $6.12B cap
Robert Half International Inc (RHI) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported RHI revenue for 2026-06-30 was $2.64B. Net income was $40.1M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
RHI currently screens at market cap $4.38B and trailing P/E 21.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the RHI and TERN stock pages for the full models.
Not investment advice.